Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 483-487

  Alfie, Marcos E ^a   Sigmon, David H ^a   Pomposiello, Silvia I ^a   Carretero, Oscar A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

bradykinin; bradykinin B2 receptor knockout mouse; kallikrein kinin system; mean arterial pressure; renal blood flow; renal vascular resistance

Indexed keywords

BRADYKININ B2 RECEPTOR; KININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIURESIS; HYPERTENSION; KALLIKREIN KININ SYSTEM; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE;

EID: 85026151937     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.483     Document Type: Article

References (23)

1. Carretero OA, Scicli AG. The kallikrein-kinin system as a regulator of cardiovascular and renal function. In: Laragh JH, Brenner BM, eds. Hypertension: Physiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995:983-999.
2. Vanhoutte PM. Endothelium and control of vascular function: state of the art lecture. Hypertension. 1989;13:658-667.
3. Regoli D. Pharmacology of bradykinin and related kinins. Adv Exp Med Biol. 1983;156:569-584.
4. Farhy RD, Carretero OA, Ho K-L, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 1993;72:1202-1210.
5. Liu Y-H, Yang X-P, Sharov VG, Sigmon DH, Sabbah HN, Carretero OA. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension. 1996;27:7-13.
6. Stauss HM, Zhu Y-C, Redlich T, Adamiak D, Mott A, Kregel KC, Unger T. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. J Cardiovasc Risk. 1994;1:255-262.
7. Scicli AG, Carretero OA. Renal kallikrein-kinin system. Kidney Int. 1986;29:120-130.
8. 2, water, and sodium excretion. Hypertension. 1995;25:1008-1013.
9. Mattson DL, Cowley AW Jr. Kinin actions on renal papillary blood flow and sodium excretion. Hypertension. 1993;21:961-965.
10. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, Kuida H, Williams RR. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension. 1989;13:3-8.
11. Woodley-Miller C, Chao J, Chao L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens. 1989;7:865-871.
12. Majima M, Yoshida O, Mihara H, Muto T, Mizogami S, Kuribayashi Y, Katori M, Oh-Ishi S. High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension. 1993;22:705-714.
13. Majima M, Mizogami S, Kuribayashi Y, Katori M, Oh-Ishi S. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension. 1994;24:111-119.
14. 2-receptors enhances the slow vasopressor response to angiotensin II. Hypertension. 1994;23:646-652.
15. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem. 1995;270:13706-13710.
16. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995;25:1111-1115.
17. 2-receptor antagonist, on renal function in conscious normotensive rats. Br J Pharmacol. 1992;106:380-386.
18. Campese VMP. Salt sensitivity in hypertension: renal and cardiovascular implications. Hypertension. 1994;23:531-550.
19. Campese VM. Hemodynamic alterations and urinary albumin excretion in patients with essential hypertension. Am J Kidney Dis. 1993;21:15-21.
20. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem. 1993;268:11617-11621.
21. Ohkubo H, Kawakami H, Kakehi Y, Takumi T, Arai H, Yokota Y, Iwai M, Tanabe Y, Masu M, Hata J, Iwao H, Okamoto H, Yokoyama M, Nomura T, Katsuki M, Nakanishi S. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1990;87:5153-5157.
22. Bader M, Zhao Y, Sander M, Lee MA, Bachmann J, Bohm M, Djavidani B, Peters J, Mullins JJ, Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension. 1992;19:681-686.
23. Deng Y, Rapp JP. Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nat Genet. 1992;1:267-272.